US and Europe Surrogacy Market to Grow at a CAGR of 19.4% to reach US$ 25,284.02 million from 2022 to 2030

The US and Europe surrogacy market size is expected to grow from US$ 6,113.72 million in 2022 to US$ 25,284.02 million in 2030; it is estimated to record a CAGR of 19.4% from 2022 to 2030.

Analyst Perspective:

Factors affecting the growth of the surrogacy market may vary across different regions and countries. The establishment of clear and favorable legal frameworks for surrogacy can encourage the growth of the US and Europe surrogacy market. In some cases, individuals or couples may turn to surrogacy due to limited adoption services or long waiting periods associated with the adoption process. Surrogacy can provide an alternative pathway to parenthood for those who are unable to adopt or prefer a genetic connection to the child. As societies become more receptive to non-traditional family structures, there has been a shift in the perspective of surrogacy. Greater awareness and understanding of the options available for family building, including surrogacy, have contributed to the growth of the US and Europe surrogacy market.  

Market Overview:

The US and Europe surrogacy market is a complex and multifaceted marketplace that involves individuals or couples, often referred to as intended parents, seeking the assistance of a surrogate mother to carry and deliver a child on their behalf. While regulations and practices vary across countries. Surrogacy can take place within a country’s borders or involve intended parents from one country seeking surrogacy services in another country. International surrogacy often occurs when individuals or couples face legal restrictions or seek more favorable conditions abroad. Surrogacy agencies and fertility clinics play a significant role in facilitating surrogacy arrangements in the US and Europe surrogacy market. These organizations help match intended parents with surrogates, coordinate medical procedures, and navigate the legal and logistic aspects of the process. Surrogacy raises various ethical, legal, and social considerations, including the rights and well-being of the surrogate’s mother, the legal parentage of the child, the potential exploitation of surrogates, and the best interests of the child. Different countries and jurisdictions approach these issues differently.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

US and Europe Surrogacy Market: Strategic Insights

Market Size Value in	US$ 6,113.72 million in 2022
Market Size Value by	US$ 25,284.02 million in 2030
Growth rate	CAGR of 19.4% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Market Driver:

Technological Advancements in Reproductive Technologies to Drive US and Europe Surrogacy Market Growth

Infertility can be treated using assisted reproductive technologies (ART), which use techniques such as in-vitro fertilization, artificial insemination, and surrogacy. These advancements have revolutionized the field of ART, providing new possibilities for individuals and couples facing fertility challenges. Due to its higher success rate, in-vitro fertilization (IVF) is projected to become the most popular method of treating infertility. As the success rates of IVF continue to rise, more individuals and couples may turn to surrogacy as an option when other fertility treatments have been unsuccessful.

Another technological advancement that would contribute to the US and Europe surrogacy market growth is preimplantation genetic testing (PGT). The PGT allows for the screening of embryos for genetic defects before transfer to the surrogate mother's uterus. This technology allows intended parents to select embryos with a higher likelihood of successful implantation and lowers the risk of genetic disorders in offspring. As PGT becomes more sophisticated and accessible, it may further drive the demand for surrogacy to achieve a healthy pregnancy. In addition, developments in gestational carrier screening provide a more comprehensive assessment of surrogate mothers' health and potential risks during pregnancy. These technologies allow for a thorough evaluation of the surrogate's suitability, increasing the confidence of intended parents. Thus, the factors mentioned above are expected to boost the US and Europe surrogacy market during the forecast period.

Segmental Analysis:

Based on technology, the US and Europe surrogacy market is categorized into intrauterine insemination (IUI) and in-vitro fertilization (IVF). In 2022, the IVF segment held a larger share of the US and Europe surrogacy market. Moreover, it is expected to register a higher CAGR in the market during 2022–2030. IVF has a higher success rate than IUI, as the embryo is directly transferred to the uterus. In the case of IVF technology, genetic testing of the embryo can be done, which can help identify genetic disorders before implantation. Moreover, embryos can be frozen after fertilization if the intended parents want delayed conception; frozen embryos can also be used upon the failure of previous IVF cycles. IVF can be performed via two techniques: classical/standard IVF and intracytoplasmic sperm injection (ICSI). In February 2023, Bumrungrad launched its fertility center and IVF clinic to deliver holistic reproductive care, from consultation to assisted reproductive technology to the clients. In October 2022, TMRW Life Sciences, Inc. launched the world's most advanced cryo-storage facility for fertility specimens. This technology-enabled facility, located in New York, delivers a new standard of care directly to patients for the first time and to fertility clinic partners providing unprecedented levels of transparency of frozen eggs and embryos at the heart of almost every IVF journey.

Regional Analysis:

The US surrogacy market was valued at US$ 4,207.37 million in 2022 and is projected to reach US$ 17,265.05 million by 2030; it is expected to grow at a CAGR of 19.3% during the forecast period. The US held the largest share of the US and Europe surrogacy market in 2022. The market growth in this country is attributed to the increasing cases of infertility, an emerging trend of late pregnancies, and a rise in the rate of gamete donations. The availability of fertility treatments, increased awareness about infertility, an upsurge in disposable income, and the enactment of favorable reimbursement policies further drive the surrogacy market growth in the US. Stringent surrogacy legislation due to the "Baby M" case in 1986 prompted many surrogacy service providers to adopt gestational practices to avoid legal penalties. However, as the demand remained steady, these laws had little impact on the growth of the surrogacy industry. The subsequent expansion of fertility and surrogacy clinics, and a rise in same-sex marriages are anticipated to create attractive growth possibilities for the US and Europe surrogacy market.

Financial aspects also play a role in the growth of the US surrogacy market. While the costs associated with surrogacy can vary significantly, clinics in the US offer a range of options catering to different budget scenarios. According to American Fertility Services (AFS), surrogacy costs in the US range from US$ 60,000 to US$ 150,000; the total costs may vary in every case. Further, the availability of insurance coverage for surrogacy-related medical expenses and competitive pricing structures benefits the surrogacy industry in the US.

Key Player Analysis:

The US and Europe surrogacy market analysis is based on the performance profiles of London Women's Clinic, The Centre for Reproductive and Genetic Health, Global Surrogacy, Miracle Baby Surrogacy, Lotus Surrogacy, VittoriaVita, Circle Surrogacy and Egg Donation, Redia IVF, New Life Ukraine, and Sensible Surrogacy, among others.

Recent Developments:

 

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the US and Europe surrogacy market. A few recent key market developments in the US and Europe surrogacy market are listed below:

• In March 2023, Ovation Fertility and US Fertility signed a definitive agreement, and they completed a successful federal regulatory evaluation process post that, creating the leading fertility platform in the US. Together, these companies provide advanced fertility care through 28 laboratories established in more than 90 locations.
• In April 2023, acquired two fertility clinics in Bromley and Eastbourne and a satellite centre at Brighton. London Women’s Clinic offers its world-leading services in reproductive medicine across the entire South-East region.